The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
E-cadherin expression in primary carcinomas of the breast and its distant metastases
Open accessAbstract
INTRODUCTION: Aberrant expression of E-cadherin has been associated with the development of metastases in patients with breast cancer. Even though the expression of E-cadherin has been studied in primary breast tumors, little is known about its expression at the distant metastatic sites. We investigate the relationship between E-cadherin expression in primary breast carcinoma and their distant, non-nodal metastases. METHODS: Immunohistochemical analysis of E-cadherin was performed in tissues from 30 patients with primary invasive breast carcinoma and their distant metastases. E-cadherin expression was evaluated as normal or aberrant (decreased when compared with normal internal positive controls, or absent). RESULTS: Twenty-two (73%) invasive carcinomas were ductal, and eight (27%) were lobular. Of the primary invasive ductal carcinomas, 55% (12/22) had normal E-cadherin expression and 45% (10/22) had aberrant expression. All of the metastases expressed E-cadherin with the same intensity as (12 tumors) or with stronger intensity than (10 tumors) the corresponding primaries. Of the invasive lobular carcinomas, one of eight (12%) primary carcinomas and none of the metastases expressed E-cadherin in the cell membranes, but they accumulated the protein in the cytoplasm. CONCLUSION: Aberrant E-cadherin expression is frequent in invasive ductal carcinomas that progress to develop distant metastases. Distant metastases consistently express E-cadherin, often more strongly than the primary tumor. Invasive lobular carcinomas have a different pattern of E-cadherin expression, suggesting a different role for E-cadherin in this form of breast carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
Pathological prognostic factors in breast cancer
Elston, C. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,735
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551
The Nottingham prognostic index in primary breast cancer
Galea, M. H., Blamey, R. W., Elston, C. E., & Ellis, I. O. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840834 · Cited by 1,070
Regulation of Cadherin Adhesive Activity
Gumbiner, B. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.3.399 · Cited by 787
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
A prognostic index in primary breast cancer
Haybittle, J. L., Blamey, R. W., Elston, C. W., Johnson, J., Doyle, P. J., Campbell, F. C., Nicholson, R. I., & Griffiths, K. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.62 · Cited by 699
Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., & Takeichi, M. (1993) · PubMed · Cited by 661
Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas.
Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M., & Abe, O. (1989) · PubMed · Cited by 596
Seidman, A. D., Fornier, M. N., Esteva, F. J., Tan, L., Kaptain, S., Bach, A., Panageas, K. S., Arroyo, C., Valero, V., Currie, V., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2587 · Cited by 547
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
Umbas, R., Isaacs, W. B., Bringuier, P., Schaafsma, H. E., Karthaus, H. F. M., Oosterhof, G. O. N., Debruyne, F. M. J., & Schalken, J. A. (1994) · PubMed · Cited by 529
Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll, R., Mitze, M., Frixen, U. H., & Birchmeier, W. (1993) · PubMed · Cited by 520
Berx, G., Cleton-Jansen, A., Strumane, K., de Leeuw, W. J., Nollet, F., Roy, F. M. V., & Cornelisse, C. J. (1996) · PubMed · Cited by 461
Mayer, B., Johnson, J. P., Leitl, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., Birchmeier, W., & Funke, I. (1993) · PubMed · Cited by 440
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
Rosen, P. R., Groshen, S., Saigo, P. E., Kinne, D. W., & Hellman, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.3.355 · Cited by 415
Gamallo, C., Palacios, J., Suarez, A., Pizarro, Á., Navarro, P., Quintanilla, M., & Cano, A. (1993) · PubMed · Cited by 410
β-Catenin as Oncogene--The Smoking Gun
Peifer, M. (1997) · Science · doi:10.1126/science.275.5307.1752 · Cited by 327
de Leeuw, W. J. F., Berx, G., Vos, C. B. J., Peterse, J. L., Van de Vijver, M. J., Litvinov, S., Van Roy, F., Cornelisse, C. J., & Cleton-Jansen, A.-M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199712)183:4<404::aid-path1148>3.0.co;2-9 · Cited by 306
Nass, S. J., Herman, J. G., Gabrielson, E. W., Iversen, P. W., Parl, F. F., Davidson, N. E., & Graff, J. R. (2000) · PubMed · Cited by 292
Shore, E. M., & Nelson, W. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55045-6 · Cited by 224
Persistent E-Cadherin Expression in Inflammatory Breast Cancer
Kleer, C. G., van Golen, K. L., Braun, T., & Merajver, S. D. (2001) · Modern Pathology · doi:10.1038/modpathol.3880334 · Cited by 214
Self-citationSarrió, D., Moreno‐Bueno, G., Hardisson, D., Sánchez‐Estévez, C., Guo, M., Herman, J. G., Gamallo, C., Esteller, M., & Palacios, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11197 · Cited by 209
Bukholm, I. K., Nesland, J. M., & B�rresen-Dale, A.-L. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1<15::aid-path489>3.0.co;2-l · Cited by 208
Epithelial (E‐) and placentae (P‐) cadherin cell adhesion molecule expression in breast carcinoma
Rasbridge, S. A., Gillett, C. E., Sampson, S. A., Walsh, F. S., & Millis, R. R. (1993) · The Journal of Pathology · doi:10.1002/path.1711690211 · Cited by 201
Bukholm, I. K., Nesland, J. M., Kåresen, R., Jacobsen, U., & Børresen‐Dale, A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<262::aid-path97>3.0.co;2-y · Cited by 188
Palacios, J., Benito, N., Pizarro, Á., et al. (1995) · PubMed · Cited by 163
Pierceall, W. E., Woodard, A. S., Morrow, J. S., Rimm, D. L., & Fearon, E. R. (1995) · PubMed · Cited by 139
Diagnosis and Management of Breast Cancer.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-782_1 · Cited by 133
Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome
Dorudi, S., Hanby, A., Poulsom, R., Northover, J. M. A., & Hart, I. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.119 · Cited by 128
Day, M. L., Zhao, X., Vallorosi, C. J., Putzi, M. J., Powell, C. T., Lin, C., & Day, K. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9656 · Cited by 119
E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
Jones, J., Royall, J., & Walker, R. A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.522 · Cited by 69
Rashid, M. G., Sanda, M. G., Vallorosi, C. J., Rios‐Doria, J., Rubin, M. A., & Day, M. L. (2001) · PubMed · Cited by 65
Self-citationThe Diagnosis of Breast Cancer
Leis, H. P. (1977) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.27.4.209 · Cited by 43
Cited by
Modelling glandular epithelial cancers in three-dimensional cultures
Debnath, J., & Brugge, J. S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1695 · Cited by 1,015
EMT, MET, Plasticity, and Tumor Metastasis
Bakir, B., Chiarella, A. M., Pitarresi, J. R., & Rustgi, A. K. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.003 · Cited by 1,010
Epithelial-mesenchymal transition in cancer development and its clinical significance
Iwatsuki, M., Mimori, K., Yokobori, T., Ishi, H., Beppu, T., Nakamori, S., Baba, H., & Mori, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01419.x · Cited by 780
Voulgari, A., & Pintzas, A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.002 · Cited by 671
The role of HER2 in cancer therapy and targeted drug delivery
Tai, W., Mahato, R., & Cheng, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.009 · Cited by 555
Metadata
- Authors
- Kowalski, P. J., Rubin, M. A., & Kleer, C. G.
- Venue
- Breast Cancer Research
- Published
- 2003-09-26
- Volume
- 5
- Issue
- 6
- Pages
- R217-22
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2103992634
- Cited by
- 414
- References
- 34
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.